2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow ozanimod: new trials by email Literature Review of ozanimod trials Research Report on ozanimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy Ozanimod - Crohn Disease | Phase 2 / Phase 3 | Terminated | Bristol-Myers Squibb | 5 | 2023-08-22 | 2025-04-22 |
| COVID-19 Ozanimod Intervention Study Ozanimod, Standard of care - COVID-19 | Phase 2 | Terminated | Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 43 | 2020-09-16 | 2024-02-20 |
COVID-19 (1) · Crohn Disease (1)
Bristol-Myers Squibb (1) · Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (1)
Canada (2) · Australia (1) · Belgium (1) · France (1) · Germany (1) · Hungary (1) · Poland (1) · Spain (1) · United States (1)
David Marsolais, PhD (1) · Pascale Blais-Lecours, PhD (1)